newsfilter
← Latest News
Business Wire·

HeartBeam Reports Second Quarter 2025 Results

Executing on Commercial Readiness Plans in Anticipation of FDA 510(k) Clearance for Groundbreaking 12-lead Electrocardiogram (ECG) Synthesis Software Engaged in Ongoing Productive Discussions with FDA Related to the